| PERIOD ENDING | 1-Nov-09 | 2-Aug-09 | 3-May-09 | 25-Jan-09 | | Total Revenue | 958,900 | 813,700 | 1,057,400 | 942,300 | | Cost of Revenue | 649,700 | 553,800 | 729,600 | 659,800 | | | Gross Profit | 309,200 | 259,900 | 327,800 | 282,500 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 168,600 | 139,000 | 193,200 | 149,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 140,600 | 120,900 | 134,600 | 133,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (800) | (1,900) | (5,300) | (7,900) | | Earnings Before Interest And Taxes | 139,800 | 119,000 | 129,300 | 125,600 | | Interest Expense | 41,000 | 24,200 | 25,200 | 27,400 | | Income Before Tax | 98,800 | 94,800 | 104,100 | 98,200 | | Income Tax Expense | 36,200 | 35,900 | 35,300 | 38,600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 62,600 | 58,900 | 68,800 | 59,600 | | | Non-recurring Events | | Discontinued Operations |
-
| (300) | 2,700 | 900 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 62,600 | 58,600 | 71,500 | 60,500 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $62,600 | $58,600 | $71,500 | $60,500 |
|
1.27% Nasdaq 
Income Statement
